Tumor Necrosis Factor-α Monoclonal Antibody, Infliximab, Used to Manage Severe Sciatica-Reference-Cited by-同舟云学术

Tumor Necrosis Factor-α Monoclonal Antibody, Infliximab, Used to Manage Severe Sciatica

Published:2003-04 Issue:8 Volume:28 Page:750-753
ISSN:0362-2436
Container-title:Spine
language:en
Short-container-title:Spine

Author:

Karppinen Jaro,Korhonen Timo,Malmivaara Antti,Paimela Leena,Kyllönen Eero,Lindgren Karl-August,Rantanen Pekka,Tervonen Osmo,Niinimäki Jaakko,Seitsalo Seppo,Hurri Heikki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Orthopedics and Sports Medicine

Reference19 articles.

1. The Inflammatory Effect of Nucleus Pulposus

2. Inflammatogenic Properties of Nucleus Pulposus

3. Autologous Nucleus Pulposus Induces Neurophysiologic and Histologic Changes in Porcine Cauda Equina Nerve Roots

4. Exogenous Tumor Necrosis Factor-Alpha Mimics Nucleus Pulposus-Induced Neuropathology

5. Tumor Necrosis Factor: Function, Release and Clearance

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathology of pain and its implications for therapeutic interventions;Signal Transduction and Targeted Therapy;2024-06-08

2. Bandscheibenvorfall - immunologische Argumente für konservative Verfahren;Schmerzmedizin;2023-07

3. Pain-resolving immune mechanisms in neuropathic pain;Nature Reviews Neurology;2023-03-01

4. Mode of action of astrocytes in pain: From the spinal cord to the brain;Progress in Neurobiology;2022-12

5. Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia;International Journal of Molecular Sciences;2022-05-30